Blood Tests for Early Cancer; Rethinking Asbestos Ban; Reducing Depression in Cancer



(MedPage Today) — Grail announced that results from the registrational PATHFINDER 2 study of its Galleri multi-cancer early detection test showed that adding the test to standard-of-care screening resulted in substantially greater additional cancer…



Source link : https://www.medpagetoday.com/hematologyoncology/othercancers/116175

Author :

Publish date : 2025-06-20 19:30:00

Copyright for syndicated content belongs to the linked Source.
Exit mobile version